Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Cord Blood Bank is a specialized biotechnology institution focused on the collection, laboratory testing, cryogenic preservation, and clinical distribution of umbilical cord blood stem cells. As one of the seven licensed cord blood banks in China authorized by the National Health Commission, it operates under the technical guidance of Qilu Hospital of Shandong University. The company provides both public donation services and private storage for families, supporting the treatment of over 80 types of hematological and immunological diseases. Its facilities include advanced cleanrooms and automated storage systems designed to ensure the long-term viability of hematopoietic stem cells for clinical transplantation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Cord Blood Bank.